Previous Page  2 / 21 Next Page
Information
Show Menu
Previous Page 2 / 21 Next Page
Page Background

Volume 7, Issue 10 (Suppl)

Gynecol Obstet (Sunnyvale), an open access journal

ISSN: 2161-0932

Gynecology 2017

October 02-04, 2017

Page 24

conference

series

.com

4

th

International Conference on

Gynecology & Obstetrics

October 02-04, 2017 Barcelona, Spain

Greg J Marchand, Gynecol Obstet (Sunnyvale) 2017, 7:10(Suppl)

DOI: 10.4172/2161-0932-C1-021

Successful complete laparoscopic staging of ovarian cancer in a patient with a 17 cm malignant

ovarian tumor

A

47-year-old nulligravid, morbidly obese, Caucasian female had a history of a 6 cm left adnexal cystic mass that had been

followed for greater than two years. During that time, there was no significant change in character of the mass and the

patient’s CA-125 levels remained within normal limits for a pre-menopausal female. The patient had an onset of severe lower

pelvic pain following a vigorous workout and arrived to the Emergency Department complaining of severe primarily lower

abdominal and pelvic pain. Trans-vaginal ultrasound and computed tomography scan revealed a large right-sided complex

adnexal mass. In recent years, the use of electro-mechanical morcellation in gynecological surgeries has become a point

of controversy. The United States Food and Drug Administration released a safety communication in 2014 on the risks of

dissemination of malignancies when using electro-mechanical morcellation. This new technique effectively minimizes these

risks by using blunt instruments to cautiously transfer a large mass into a containment bag for morcellation and removal, while

avoiding rupture of the bag itself. After this patient’s tumor was removed, the remainder of the staging procedure was also able

to be completed laparoscopically, an outcome that can make a very large difference to cancer patients especially. This method

opens up discussion on more widespread use of minimally invasive surgery. If further studies support its efficacy in preventing

tissue dissemination, it has the potential to lead to an increase in candidates for laparoscopy, the removal of larger masses

through smaller holes, and ultimately better outcomes for patients.

Biography

Greg J Marchand is a board certified Ob-Gyn who leads a practice focusing on minimally invasive surgery in Mesa, AZ. He has extensively published his research work in

minimally invasive surgery and has several world records regarding laparoscopic surgical achievements. He is a Research Director in Department of Minimally Invasive

Surgical at Marchand OBGYN. He is graduated fromArizona State University (ASU).

laudius@aol.com

Greg J Marchand

Marchand OBGYN Department of Minimally Invasive Surgery, Mesa, USA